Douglas Richard Stack
10Patents
3h-index
25Co-inventors
60Inventor score
Filing activity: Aug 31, 1998 → Sep 17, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7807691B2 | Substituted N-arylpyrrolidines as selective androgen receptor modulators | Chemistry; Metallurgy | 7 | Active |
| US6037447A | Glycopeptide compounds | Human Necessities | 5 | Expired |
| US6552013B1 | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds | Human Necessities | 4 | Expired |
| US6569851B1 | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds | Human Necessities | 3 | Expired |
| US9416138B2 | Benzyl sulfonamide compounds useful as MoGAT-2 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11999722B2 | Disubstituted pyrazole compounds | Human Necessities | 0 | Active |
| US11124500B2 | Disubstituted pyrazole compounds | Human Necessities | 0 | Active |
| US6906056B2 | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds | Human Necessities | 0 | Expired |
| US9187411B2 | Leukotriene B4 antagonist compound | Human Necessities | 0 | Active |
| US6838455B2 | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.